| Not Yet Recruiting | Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powd Respiratory | Phase 3 | 2026-04-01 |
| Recruiting | Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus Relapsing Multiple Sclerosis | Phase 3 | 2025-06-10 |
| Terminated | Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB89 Melanoma | Phase 3 | 2024-12-19 |
| Withdrawn | Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of C Common Cold | Phase 3 | 2024-09-20 |
| Active Not Recruiting | A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® i Melanoma | Phase 1 | 2024-05-15 |
| Completed | A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Particip Metastatic NSCLC | Phase 3 | 2024-04-29 |
| Terminated | Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mome Seasonal Allergic Rhinitis | Phase 1 | 2023-06-08 |
| Active Not Recruiting | Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in R Inflammatory Bowel Disease | — | 2023-02-16 |
| Completed | Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Mom Seasonal Allergic Rhinitis | Phase 3 | 2023-02-13 |
| Completed | Study of the Efficacy and Safety of Broncho-munal®, Capsules, 7 mg for the Treatment of Acute Uncomplicated Re Acute Uncomplicated Respiratory Tract Infections | Phase 3 | 2022-11-07 |
| Completed | Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit Neovascular Age-related Macular Degeneration (nAMD) | Phase 3 | 2022-05-16 |
| Completed | A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olapari Ovarian Cancer, Breast Cancer | Phase 1 | 2022-04-07 |
| Completed | Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Pa Seasonal Allergic Rhinitis | Phase 3 | 2022-04-04 |
| Completed | Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe Neovascular Age-related Macular Degeneration (nAMD) | Phase 3 | 2022-03-11 |
| Completed | Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With N Neovascular Age-related Macular Degeneration | Phase 3 | 2021-05-12 |
| Completed | Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis Rhinosinusitis | Phase 3 | 2020-10-22 |
| Completed | Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea Antibiotic-associated Diarrhea | Phase 3 | 2020-10-01 |
| Terminated | An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal P Parkinson Disease | Phase 1 | 2019-12-03 |
| Withdrawn | Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in S Kidney Transplant | Phase 1 | 2019-09-02 |
| Completed | Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients Postmenopausal Women With Osteoporosis | Phase 3 | 2019-07-02 |
| Completed | Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymalt Mild and Moderate Iron-deficiency Anaemia | Phase 3 | 2019-06-27 |
| Completed | Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease Crohn´s Disease | — | 2019-06-24 |
| Completed | This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief R Dry Skin | N/A | 2019-03-26 |
| Completed | In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy Subjects Healthy Volunteers | Phase 1 | 2018-12-26 |
| Completed | Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery Inflammation Following Ocular Surgery | Phase 1 | 2018-04-26 |
| Completed | A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia Iron Deficiency Anemia | Phase 1 | 2017-11-29 |
| Completed | A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and Sore Throat | Phase 3 | 2017-02-22 |
| Completed | Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FOR Sore Throat | Phase 3 | 2017-02-22 |
| Terminated | A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea. Travelers' Diarrhea | Phase 3 | 2016-12-15 |
| Completed | Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2016-03-31 |
| Completed | GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera® Rheumatoid Arthritis | Phase 3 | 2015-07-01 |
| Completed | Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2015-02-21 |
| Completed | Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira Plaque Type Psoriasis | Phase 3 | 2013-12-01 |
| Completed | Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel Chronic Stable Plaque Psoriasis | Phase 3 | 2013-06-01 |
| Completed | GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma Indolent B-cell Non-Hodgkin's Lymphoma | Phase 1 | 2013-05-01 |
| Completed | Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa Impulse Control Disorder | Phase 4 | 2012-11-01 |
| Completed | Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa Anemia, Chronic Kidney Disease (CKD) | Phase 3 | 2012-09-01 |
| Completed | Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® Neutropenic Complications, Breast Neoplasms, Chemotherapy-induced Neutropenia | Phase 3 | 2012-06-01 |
| Completed | HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD) Chronic Kidney Disease | Phase 3 | 2012-04-01 |
| Completed | Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim Chemotherapy-induced Neutropenia, Breast Cancer | Phase 3 | 2012-03-01 |
| Completed | Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease Parkinson's Disease | Phase 4 | 2012-02-01 |
| Completed | Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim Chemotherapy Associated Neutropenia, Breast Cancer | Phase 3 | 2011-12-01 |
| Completed | GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL) Follicular Lymphoma | Phase 3 | 2011-12-01 |
| Terminated | Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia Severe Chronic Neutropenia | Phase 4 | 2011-07-01 |
| Completed | Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors Hematopoietic Stem Cell Mobilization | — | 2011-05-01 |
| Completed | Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection Chronic Kidney Insufficiency | — | 2011-04-01 |
| Completed | GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy Rheumatoid Arthritis | Phase 1 / Phase 2 | 2011-01-01 |
| Completed | A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal All Rhinitis, Allergic, Seasonal | Phase 3 | 2010-12-27 |
| Terminated | Clinical Trial With Mesalamine 1g Suppositories Proctitis | Phase 3 | 2010-06-01 |
| Completed | Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants Wit Febrile Neutropenia, Cancer, Breast Cancer | — | 2010-03-01 |
| Completed | MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disea Chronic Kidney Disease, End-stage Renal Disease, Anaemia | — | 2010-02-01 |
| Completed | A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Sympt Rhinitis, Allergic, Seasonal | Phase 3 | 2009-12-02 |
| Terminated | Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age Short Children Born Small for Gestational Age (SGA) | N/A | 2009-07-20 |
| Completed | Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticason Asthma | Phase 2 | 2009-06-01 |
| Withdrawn | Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Ass Anemia, Chronic Renal Insufficiency | Phase 3 | 2009-04-01 |
| Completed | Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v. Chronic Kidney Disease | Phase 4 | 2008-07-01 |
| Completed | Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA) Small for Gestational Age | Phase 4 | 2008-02-06 |
| Completed | Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions Pain | Phase 1 | 2007-11-01 |
| Completed | Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions Pain | Phase 1 | 2007-11-01 |
| Terminated | Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Sub Anemia, Chronic Renal Insufficiency | Phase 3 | 2007-09-01 |
| Completed | Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions Seizures | Phase 1 | 2006-10-01 |
| Completed | Relative Bioavailability of a Fentanyl Patch Pain | Phase 1 | 2006-09-01 |
| Completed | Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subj Prostate Cancer, Hirsutism | Phase 1 | 2006-08-01 |
| Completed | A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules Inflammation | Phase 1 | 2006-06-01 |
| Completed | Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions Hypertension | Phase 1 | 2006-06-01 |
| Completed | Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subj Prostate Cancer, Hirsutism | Phase 1 | 2006-06-01 |
| Completed | Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions Hypertension | Phase 1 | 2006-06-01 |
| Completed | A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions Type 2 Diabetes | Phase 1 | 2005-11-01 |
| Completed | To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Cond Epilepsy, Bipolar Disorder | Phase 1 | 2005-10-01 |
| Completed | To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Epilepsy, Bipolar Disorder | Phase 1 | 2005-10-01 |
| Completed | A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions Depression | Phase 1 | 2005-09-01 |
| Completed | To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 Allergies | Phase 1 | 2005-07-01 |
| Completed | To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hyd Depression | Phase 1 | 2005-07-01 |
| Completed | To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 Allergies | Phase 1 | 2005-06-01 |
| Completed | To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets Allergy | Phase 1 | 2005-06-01 |
| Completed | To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed Conditions Healthy | Phase 1 | 2005-04-01 |
| Completed | To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions Healthy | Phase 1 | 2005-04-01 |
| Completed | To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250 mg/5 ml Oral Suspension Fed Conditions Healthy | Phase 1 | 2005-04-01 |
| Completed | To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditio Healthy | Phase 1 | 2005-04-01 |
| Completed | Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Anemia | Phase 3 | 2004-11-01 |
| Completed | To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions Hypertension | Phase 1 | 2004-10-01 |
| Completed | To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions Hypertension | Phase 1 | 2004-10-01 |
| Completed | To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Condition Nausea, Vomiting | Phase 1 | 2004-09-01 |
| Completed | To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions Nausea, Vomiting | Phase 1 | 2004-09-01 |
| Completed | Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Condit Infections | Phase 1 | 2004-08-01 |
| Completed | To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions Allergy | Phase 1 | 2004-07-01 |
| Completed | To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions Healthy | Phase 1 | 2004-06-01 |
| Completed | To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Healthy | Phase 1 | 2004-05-01 |
| Completed | Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialy Anemia | Phase 3 | 2004-04-01 |
| Completed | To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions Healthy | Phase 1 | 2004-03-01 |
| Completed | To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Con Depression | Phase 1 | 2004-03-01 |
| Completed | To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam T Seizure | Phase 1 | 2004-03-01 |
| Completed | To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions Healthy | Phase 1 | 2004-03-01 |
| Completed | To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions Pain | Phase 1 | 2004-01-01 |
| Completed | To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions Infection | Phase 1 | 2003-08-01 |
| Completed | Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions Infection | Phase 1 | 2003-08-01 |
| Completed | To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditi Rheumatoid Arthritis, Psoriatic Arthritis | Phase 1 | 2002-09-01 |
| Completed | To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2002-06-01 |
| Completed | To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions Healthy | Phase 1 | 2002-05-01 |
| Completed | Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg) Rheumatoid Arthritis, Osteoarthritis | Phase 1 | 2002-03-01 |
| Completed | To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fastin Type II Diabetes | Phase 1 | 2001-06-01 |
| Completed | Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fast Chronic Hepatitis C | Phase 1 | 2001-04-01 |
| Completed | To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg Depression | Phase 1 | 2001-02-01 |
| Completed | Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Chronic Hepatitis C | Phase 1 | 2001-01-01 |
| Completed | To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg Angina, Hypertension | Phase 1 | 2000-11-01 |
| Completed | To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed Hypertension | Phase 1 | 2000-05-01 |
| Completed | To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions Hypertension | Phase 1 | 2000-03-01 |
| Completed | To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions Healthy | Phase 1 | 1998-10-01 |
| Completed | To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsul Depression | Phase 1 | 1996-06-01 |
| Completed | To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsul Depression | Phase 1 | 1996-05-01 |
| Completed | To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg Anxiety | Phase 1 | 1996-02-01 |
| Completed | Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions High Blood Pressure, Migraine Headaches, Chest Pain | Phase 1 | 1994-07-01 |
| Completed | To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride C Depression | Phase 1 | 1994-04-01 |
| Completed | To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fastin Inflammation | Phase 1 | 1994-04-01 |
| Completed | To Demonstrate the Effect of Food on the Bioavailability of Glipizide Type 2 Diabetes | Phase 1 | 1993-11-01 |
| Completed | To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fastin Inflammation | Phase 1 | 1993-08-01 |
| Completed | To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets Immunosuppression, Rheumatism | Phase 1 | 1993-07-01 |
| Completed | To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Inflammation | Phase 1 | 1993-04-01 |
| Completed | To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride C Depression | Phase 1 | 1992-11-01 |
| Completed | To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucot Type 2 Diabetes | Phase 1 | 1992-10-01 |
| Completed | To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg Anxiety | Phase 1 | 1991-11-01 |
| Completed | To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets Allergy | Phase 1 | 1989-12-01 |
| Completed | To Demonstrate the Relative Bioavailability of Atenolol Tablets Hypertension | Phase 1 | 1989-07-01 |
| Completed | To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets Depression | Phase 1 | 1988-11-01 |
| Completed | To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets Depression | Phase 1 | 1987-12-01 |
| Completed | To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg No Depression | Phase 1 | 1987-12-01 |
| Completed | To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets Depression | Phase 1 | 1987-07-01 |
| Completed | To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers Psychosis | Phase 1 | 1987-04-01 |
| Completed | A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombina HIV Infections, Cytopenias | Phase 1 | — |
| Completed | A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS Diarrhea, HIV Infections | N/A | — |
| Completed | A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage HIV Infections, Cytopenias | N/A | — |
| Completed | A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Mono Cytomegalovirus Retinitis, HIV Infections | Phase 1 | — |
| Completed | A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in HIV Infections, Cytopenias | Phase 1 | — |
| Completed | A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti- Cytomegalovirus Infections, HIV Infections | Phase 1 | — |
| Completed | An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Viru HIV Infections, Cytopenias | Phase 1 | — |
| Completed | To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Ta Depression | Phase 1 | — |
| Completed | A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 2 Diarrhea, HIV Infections | N/A | — |
| Completed | A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia HIV Infections, Cytopenias | Phase 1 | — |
| Completed | A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients Wi HIV Infections, Cytopenias | N/A | — |